Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
Saved in:
| Title: | Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification. |
|---|---|
| Authors: | Mutch D; Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, Missouri, USA., Gaffney D; Department of Radiation Oncology, University of Utah, Salt Lake City, Utah, USA., Matias-Guiu X; Department of Pathology, Centro de Investigación Biomédica en Red de Cáncer, Instituto de Investigación Biomédica de BellvitgeHospital U de Bellvitge and Hospital U Arnau de Vilanova, Universities of Lleida and Barcelona, Barcelona, Spain., Fotopoulou C; Gynaecological Oncology, Department of Surgery and Cancer, Imperial College London, London, UK., Concin N; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.; Kliniken Essen- Mitte, Essen, Germany., Berek JS; Stanford University School of Medicine, Stanford Women's Cancer Center, Stanford Cancer Institute, Stanford, California, USA. |
| Corporate Authors: | FIGO Endometrial Cancer Subcommittee |
| Source: | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2024 Jun; Vol. 165 (3), pp. 1304-1305. Date of Electronic Publication: 2024 Mar 21. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0210174 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3479 (Electronic) Linking ISSN: 00207292 NLM ISO Abbreviation: Int J Gynaecol Obstet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
